SEARCH

SEARCH BY CITATION

References

  • Baraban S. C., Hollopeter G., Erickson J. C., Schwartzkroin P. A. and Palmiter R. D. (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17, 89278936.
  • Bellmann R., Humpel C., Krause J. E., Marksteiner J., Saria A. and Sperk G. (1991) Differential changes in mRNAs encoding for preprotachykinin A and B after kainic acid-induced seizures in the rat. Synapse 8, 7173.
  • Ben-Ari Y. (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14, 375403.
  • Borges K., McDermott D. L. and Dingledine R. (2004) Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice. Exp. Neurol. 188, 110.
  • Bregola G., Dumont Y., Fournier A., Zucchini S., Quirion R. and Simonato M. (2000) Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy. Neuroscience 98, 697703.
  • Causing C. G., Makus K. D., Ma Y., Miller F. D. and Colmers W. F. (1996) Selective upregulation of T alpha 1 alpha-tubulin and neuropeptide Y mRNAs after intermittent excitatory stimulation in adult rat hippocampus in vivo. J. Comp. Neurol. 367, 132146.
  • Cavadas C., Silva A. P., Mosimann F., Cotrim M. D., Ribeiro C. A., Brunner H. R. and Grouzmann E. (2001) NPY regulates catecholamine secretion from human adrenal chromaffin cells. J. Clin. Endocrinol. Metab. 86, 59565963.
  • Gobbi M., Gariboldi M., Piwko C., Hoyer D., Sperk G. and Vezzani A. (1998) Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J. Neurochem. 70, 16151622.
  • Greber S., Schwarzer C. and Sperk G. (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippomcampal slices in vitro. Br. J. Pharmacol. 113, 737740.
  • Grouzmann E., Aubert J. F., Waeber B. and Brunner H. R. A. (1992) Sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y. Peptides 13, 10491054.DOI: 10.1016/0196-9781(92)90004-M
  • Klapstein G. J. and Colmers W. F. (1993) On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3, 103112.
  • Kofler N., Kirchmair E., Schwarzer C. and Sperk G. (1997) Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats. Neurosci. Lett. 230, 129132.DOI: 10.1016/S0304-3940(97)00492-8
  • Kopp J., Nanobashvili A., Kokaia Z., Lindvall O. and Hökfelt T. (1999) Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Mol. Brain Res. 72, 1729.DOI: 10.1016/S0169-328X(99)00191-6
  • Layne E. (1957) Spectophotometric and turbidimetric methods for measuring proteins, in Methods in Enzymology (ColowickS. P. and KaplanN. O., eds), Vol. 3, pp. 447451. Academic Press, New York.
  • Malva J. O., Carvalho A. P. and Carvalho C. M. (1996) Domoic acid induces the release of glutamate in the rat hippocampal CA3 sub-region. Neuroreport 7, 13301344.
  • Marsh D. J., Baraban S. C., Hollopeter G. and Palmiter R. D. (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc. Natl Acad. Sci. USA 96, 1351813523.DOI: 10.1073/pnas.96.23.13518
  • McMahon T. H., Foran P., Dolly J. O., Verhage M., Wiegant V. M. and Nicholls D. G. (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, γ-aminobutyric acid, aspartate, and Met-en-kephalin release from synaptosomes. J. Biol. Chem. 267, 2133821343.
  • McQuiston A. R., Petrozzino J. J., Connor J. A. and Colmers W. F. (1996) Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci. 16, 14221429.
  • Michel M. C., Beck-Sickinger A., Cox H., Doods H. N., Herzog H., Larhammar D., Quirion R., Schwartz T. and Westfall T. (1998) International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143150.
  • Nicholls D. G., Sihra T. S. and Sanchez-Prieto J. (1987) Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J. Neurochem. 49, 5057.
  • Park C., Kang M., Kang K., Lee J., Kim J., Yoo J., Ahn H. and Huh Y. (2001) Differential changes in neuropeptide Y and nicotinamide adenine dinucleotide phosphate-diaphorase-positive neurons in rat hippocampus after kainic acid-induced seizure. Neurosci. Lett. 298, 4952.
  • Patrylo P. R., Van Den Pol A. N., Spencer D. D. and William son A. (1999) NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J. Neurophysiol. 82, 478483.
  • Qian J., Colmers W. and Saggau P. (1997) Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: Modulation of presynaptic Ca2+ entry. J. Neurosci. 17, 81698177.
  • Reibel S., Nadi S., Benmaamar R., Larmet Y., Carnahan J., Marescaux C. and Depaulis A. (2001) Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation. Peptides 22, 529539.DOI: 10.1016/S0196-9781(01)00347-3
  • Richichi C., Lin E. J., Stefanin D., Colella D., Ravizza T., Grignaschi G., Veglianese P., Sperk G., During M. J. and Vezzani A. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci. 24, 30513059.
  • Röder C., Schwarzer C., Vezzani A., Gobbi M., Minnini T. and Sperk G. (1996) Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience 70, 4755.DOI: 10.1016/0306-4522(95)00332-D
  • Schwarzer C. , Williamson J. M., Lothman E. W., Vezzani A. and Sperk G. (1995) Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience 69, 831845.DOI: 10.1016/0306-4522(95)00268-N
  • Schwarzer C., Sperk G., Rizzi M., Gariboldi M. and Vezzani A. (1996) Neuropeptides-immunochemistry and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev. 22, 2750.DOI: 10.1016/0165-0173(96)00005-7
  • Schwarzer C., Kofler N. and Sperk G. (1998) Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol. Pharmacol. 53, 613.
  • Silva A. P., Carvalho A. P., Carvalho C. M. and Malva J. O. (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J. Neurochem. 79, 286296.DOI: 10.1046/j.1471-4159.2001.00560.x
  • Silva A. P., Carvalho A. P., Carvalho C. M. and Malva J. O. (2003a) Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 42, 282292.DOI: 10.1016/S0028-3908(02)00382-9
  • Silva A. P., Pinheiro P. S., Carvalho A. P., Carvalho C. M., Jakobsen B., Zimmer J. and Malva J. O. (2003b) Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J. 17, 11181120.
  • Smialowska M., Bijak M., Sopala M. and Tokarski K. (1996) Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study. Neuropeptides 30, 712.DOI: 10.1016/S0143-4179(96)90048-7
  • Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J. and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 7685.DOI: 10.1016/0003-2697(85)90442-7
  • Sperk G., Lassmann H., Baran H., Kish S. J., Seitelberger F. and Hornykiewicz O. (1983) Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10, 13011315.DOI: 10.1016/0306-4522(83)90113-6
  • Vezzani A., Sperk G. and Colmers F. (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22, 2530.DOI: 10.1016/S0166-2236(98)01284-3
  • Vezzani A., Rizzi M., Conti M. and Samanin R. (2000) Modulatory role of neuropeptide in seizures induced in rats by stimulation of glutamate receptors. Am. Soc. Nutri. Sci. 7402, 1046S1048S.
  • Vezzani A., Michalkiewicz M., Michalkiewicz T. et al. (2002) Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110, 237243.DOI: 10.1016/S0306-4522(01)00581-4
  • Weiser T., Wieland H. A. and Doods H. N. (2000) Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices. Eur. J. Pharmacol. 404, 133136.DOI: 10.1016/S0014-2999(00)00478-7
  • Whittaker E., Vereker E. and Lynch M. A. (1999) Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus. Brain Res. 827, 229233.DOI: 10.1016/S0006-8993(99)01302-5
  • Whittaker V. P. (1984) The synaptosome, in Handbook of Neurochemistry (LajthaA., ed.), Vol. 7, pp. 139. Plenum Press, New York.
  • Woldbye D. P. D., Madsen T. M., Larsen P. J., Mikkelsen J. D. and Bolwig T. G. (1996) Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737, 162168.DOI: 10.1016/0006-8993(96)00730-5
  • Woldbye D. P. D., Larsen P. J., Mikkelsen J. D., Klemp K., Madsen T. M. and Bolwig T. G. (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med. 3, 761764.DOI: 10.1038/nm0797-761